ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,287.30
0.07%
Dow Jones
44,910.65
0.42%
Gold vs US Dollar
2,649.87
0.00%
Brent Oil
71.98
-0.08%
Bitcoin
96,779.98
-0.72%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Moderna Inc (MRNA)

  7. Moderna Inc (MRNA) News

Moderna (MRNA)

Moderna Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MRNA
DateTimeSourceHeadlineSymbolCompany
29/11/202420:54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRNAModerna Inc
29/11/202420:49Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRNAModerna Inc
29/11/202420:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRNAModerna Inc
12/11/202421:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRNAModerna Inc
12/11/202414:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRNAModerna Inc
08/11/202412:30PR Newswire (US)Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular CarcinomaNASDAQ:MRNAModerna Inc
07/11/202421:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRNAModerna Inc
07/11/202411:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNAModerna Inc
07/11/202411:19IH Market NewsU.S. Futures Rise as Investors Await Fed Rate Decision; Oil Prices DropNASDAQ:MRNAModerna Inc
06/11/202411:09IH Market NewsTrump Media Shares Surge 32% Pre-Market; Tesla Jumps 13%; Coinbase Rises with BTC All-Time HighNASDAQ:MRNAModerna Inc
05/11/202414:05PR Newswire (US)Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024NASDAQ:MRNAModerna Inc
28/10/202410:45Business WireMerck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)NASDAQ:MRNAModerna Inc
23/10/202412:00PR Newswire (US)Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering IntelligenceNASDAQ:MRNAModerna Inc
08/10/202420:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRNAModerna Inc
07/10/202409:45PR Newswire (US)Shareholders of Moderna, Inc. Should Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNANASDAQ:MRNAModerna Inc
04/10/202412:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRNAModerna Inc
04/10/202412:49Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MRNAModerna Inc
03/10/202412:00PR Newswire (US)Invaio Sciences Appoints André Andonian as Chairman of the Board of DirectorsNASDAQ:MRNAModerna Inc
02/10/202411:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNAModerna Inc
30/09/202409:45PR Newswire (US)MRNA LAWSUIT ALERT: The Gross Law Firm Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineNASDAQ:MRNAModerna Inc
26/09/202409:45PR Newswire (US)Shareholders that lost money on Moderna, Inc.(MRNA) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:MRNAModerna Inc
23/09/202409:45PR Newswire (US)Moderna, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNANASDAQ:MRNAModerna Inc
19/09/202409:45PR Newswire (US)The Gross Law Firm Reminds Moderna, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 - MRNANASDAQ:MRNAModerna Inc
16/09/202409:45PR Newswire (US)MRNA LAWSUIT ALERT: The Gross Law Firm Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineNASDAQ:MRNAModerna Inc
13/09/202410:12IH Market NewsOpenAI Unveils Strawberry AI Model Series; Boeing Stock Falls 4% Amid Strike; HR Surges 20% on Growth ForecastNASDAQ:MRNAModerna Inc
12/09/202410:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRNAModerna Inc
12/09/202409:45PR Newswire (US)Moderna, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - MRNANASDAQ:MRNAModerna Inc
10/09/202420:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRNAModerna Inc
10/09/202411:30PR Newswire (US)Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune DiseasesNASDAQ:MRNAModerna Inc
09/09/202419:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MRNAModerna Inc
 Showing the most relevant articles for your search:NASDAQ:MRNA

Your Recent History

LSE
SYME
Supply@me Capital
LSE
ALBA
Alba Mineral Resources
LSE
PREM
Premier African Minerals
LSE
SCE
Surface Transforms
LSE
GGP
Greatland Gold
LSE
MNL
Manchester & London Inve...
LSE
BOO
Boohoo
LSE
EPP
Energypathways
LSE
NESF
Nextenergy Solar
LSE
LLOY
Lloyds Banking
LSE
REL
Relx
LSE
JSE
Jadestone Energy
LSE
GAW
Games Workshop
LSE
CARD
Card Factory
LSE
SCLP
Scancell
LSE
EMG
Man
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 50%* for Level 2 Lite

    1 year 30%, 2 years 40% and *3 years 50%

    *Across 3 years £2132.64 only 1066.32